Vestal Point Capital, LP - 30 Sep 2025 SCHEDULE 13G/A Report for KalVista Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (KALV)

Filing Manager: Vestal Point Capital, LP
Reporting Manager: Vestal Point Capital, LP
Security: KalVista Pharmaceuticals, Inc. Common Stock, par value $0.001 per share
Symbol: KALV
Shares outstanding: 50,000,000 shares
Disclosed Ownership: 750,000 shares
Ownership: 1.5%
Form type: SCHEDULE 13G/A
Filing time: 14 Nov 2025, 16:03:32 UTC
Date of event: 30 Sep 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Vestal Point Capital, LP	1.5%	750,000	0	750,000	/s/ Ryan Wilder	By: Vestal Point Capital, LLC, General Partner, By: Ryan Wilder, Chief Investment Officer and Managing Partner
Ryan Wilder	1.5%	750,000	0	750,000	/s/ Ryan Wilder	Ryan Wilder, Individually